EUVIMEDEUVIMED entdecken
Crossref

High Ubiquitin-like Protein 3 Expression Is Associated With Prolonged Recurrence-free Survival in Non-muscle-invasive Bladder Cancer

Asuka Sano, Keita Tamura, Yasuhiro Sakai, Tomoaki Kahyo, Shoshiro Hirayama, Keigo Sekihara, Yusuke Takanashi, Shunsuke Watanabe, Kyohei Watanabe, Yuto Matsushita, Hiromitsu Watanabe, Daisuke Motoyama und 3 weitere

Anticancer Research · 2026

DOI: 10.21873/anticanres.18454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Asuka Sano und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan; askxxx1130@gmail.com. Hauptthemen laut MEDLINE: Non-Muscle Invasive Bladder Neoplasms, Biomarkers, Tumor, Neoplasm Recurrence, Local, Ubiquitins.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Current clinicopathological factors inadequately capture the biological heterogeneity of non-muscle-invasive bladder cancer (NMIBC). This study investigated the prognostic significance of ubiquitin-like protein 3 (UBL3), a molecule involved in extracellular vesicle sorting and immune regulation, in NMIBC. MATERIALS AND METHODS: Following an exploratory analysis of public RNA-sequencing databases, we evaluated tissue samples from patients who underwent transurethral resection for primary NMIBC. A discovery cohort (n=37) was assessed for UBL3 mRNA via qRT-PCR and protein expression via immunohistochemistry (IHC) quantified using digital H-scores (QuPath). A separate internal validation cohort (n=192) was subsequently evaluated by IHC. The primary endpoint was recurrence-free survival (RFS). RESULTS: The database analysis indicated that high UBL3 expression was associated with longer RFS in early-stage bladder cancer. In the discovery cohort, higher UBL3 mRNA levels were associated with prolonged RFS [hazard ratio (HR)=0.33, p=0.004]. mRNA levels also were associated with digital H-scores (ρ=0.39, p=0.018). In the separate internal validation cohort, elevated UBL3 protein expression was associated with a reduced risk of recurrence. A multivariable Cox regression confirmed that a higher UBL3 H-score (HR=0.95 per 10-point increase, p=0.023), alongside a negative preoperative urine cytology and immediate intravesical chemotherapy, remained independently associated with RFS. CONCLUSION: Elevated UBL3 expression was associated with prolonged RFS in patients with NMIBC following transurethral resection of bladder tumor. While UBL3 has potential as a prognostic biomarker, establishing its definitive clinical utility will require mechanistic investigations and validation across independent, multicenter cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-Muscle Invasive Bladder NeoplasmsBiomarkers, TumorNeoplasm Recurrence, LocalUbiquitinsUrinary Bladder NeoplasmsHumansFemaleMalePrognosisAgedTransurethral Resection of BladderMiddle AgedDisease-Free SurvivalGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Non-muscle-invasive bladder cancerUBL3immunohistochemistryprognostic biomarkerrecurrence-free survival

Substanzen

Biomarkers, TumorUbiquitins

Autor:innen und Institutionen

  • Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan; askxxx1130@gmail.com.
  • Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Department of Cellular and Molecular Anatomy, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • First Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Department of Developed Studies for Advanced Robotic Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Zitieren

APA

Sano, A., Tamura, K., Sakai, Y., Kahyo, T., Hirayama, S., Sekihara, K., Takanashi, Y., Watanabe, S., Watanabe, K., Matsushita, Y., Watanabe, H., Motoyama, D., Otsuka, A., Inamoto, T., & Setou, M. (2026). High Ubiquitin-like Protein 3 Expression Is Associated With Prolonged Recurrence-free Survival in Non-muscle-invasive Bladder Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.18454

Vancouver

Sano A, Tamura K, Sakai Y, Kahyo T, Hirayama S, Sekihara K, et al. High Ubiquitin-like Protein 3 Expression Is Associated With Prolonged Recurrence-free Survival in Non-muscle-invasive Bladder Cancer. Anticancer Research. 2026. doi:10.21873/anticanres.18454

BibTeX
@article{Sano2026,
  author = {Sano, Asuka and Tamura, Keita and Sakai, Yasuhiro and Kahyo, Tomoaki and Hirayama, Shoshiro and Sekihara, Keigo and Takanashi, Yusuke and Watanabe, Shunsuke and Watanabe, Kyohei and Matsushita, Yuto and Watanabe, Hiromitsu and Motoyama, Daisuke and Otsuka, Atsushi and Inamoto, Teruo and Setou, Mitsutoshi},
  title = {High Ubiquitin-like Protein 3 Expression Is Associated With Prolonged Recurrence-free Survival in Non-muscle-invasive Bladder Cancer},
  journal = {Anticancer Research},
  year = {2026},
  doi = {10.21873/anticanres.18454}
}
Kostenlos starten →